Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors.

Cancer research - 15 May 1993

Végh Z, Wang P, Vánky F, Klein E

Abstract excerpt

We studied the expression of major histocompatibility complex (MHC) class I molecule in 52 ex-vivo tumor samples comprising 29 ovarian, 15 lung, 1 breast, and 4 colon carcinomas; 1 midgut carcinoid; and 2 malignant mesenchymal tumors obtained from surgical specimens or from malignant effusions. The allelic products were visualized in untreated and interferon gamma + tumor necrosis factor alpha treated aliquots of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Carcinoma, Squamous Cell
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Isoelectric Focusing

Share to Lung Neoplasms

Share to Lymphocytes

Share to Ovarian Neoplasms

Share to Recombinant Proteins

Source

Identifiers

PMID: 8485728

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors.PMID 8485728Read ↗

Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.Semantic proximity Read ↗

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.Semantic proximity Read ↗

Altered MHC class I antigens in tumors.Semantic proximity Read ↗

The biological consequences of altered MHC class I expression in tumours.Semantic proximity Read ↗

Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.Semantic proximity Read ↗

High frequency of HLA-B44 allelic losses in human solid tumors.Semantic proximity Read ↗

Tumour MHC class I downregulation and immunotherapy (Review).Semantic proximity Read ↗

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.Semantic proximity Read ↗

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumorsSemantic proximity Read ↗

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.Semantic proximity Read ↗

Analysis of HLA expression in human tumor tissues.Semantic proximity Read ↗

Genetic alterations of HLA-class II in ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.